Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $3,479 | 1 | 59.5% |
| Honoraria | $1,920 | 1 | 32.8% |
| Food and Beverage | $341.13 | 3 | 5.8% |
| Education | $107.25 | 3 | 1.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $3,479 | 1 | $0 (2021) |
| Blueprint Medicines Corporation | $2,011 | 3 | $0 (2021) |
| Novartis Pharmaceuticals Corporation | $240.26 | 2 | $0 (2019) |
| Seattle Genetics, Inc. | $100.87 | 1 | $0 (2019) |
| Stemline Therapeutics Inc. | $16.75 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $5,489 | 4 | Astellas Pharma US Inc ($3,479) |
| 2020 | $16.75 | 1 | Stemline Therapeutics Inc. ($16.75) |
| 2019 | $222.90 | 2 | Novartis Pharmaceuticals Corporation ($122.03) |
| 2018 | $118.23 | 1 | Novartis Pharmaceuticals Corporation ($118.23) |
All Payment Transactions
8 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/06/2021 | Blueprint Medicines Corporation | — | Honoraria | Cash or cash equivalent | $1,920.00 | General |
| 07/14/2021 | Blueprint Medicines Corporation | — | Education | In-kind items and services | $59.00 | General |
| 07/14/2021 | Blueprint Medicines Corporation | — | Education | In-kind items and services | $31.50 | General |
| 04/01/2021 | Astellas Pharma US Inc | XOSPATA (Drug) | Consulting Fee | Cash or cash equivalent | $3,478.50 | General |
| Category: ONCOLOGY | ||||||
| 01/30/2020 | Stemline Therapeutics Inc. | ELZONRIS (Drug) | Education | In-kind items and services | $16.75 | General |
| Category: ONCOLOGY | ||||||
| 12/17/2019 | Seattle Genetics, Inc. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $100.87 | General |
| Category: Oncology | ||||||
| 10/16/2019 | Novartis Pharmaceuticals Corporation | XOLAIR (Biological) | Food and Beverage | In-kind items and services | $122.03 | General |
| Category: RESPIRATORY | ||||||
| 11/14/2018 | Novartis Pharmaceuticals Corporation | XOLAIR (Biological) | Food and Beverage | In-kind items and services | $118.23 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 13 | 1,799 | 3,810 | $518,532 | $132,839 |
| 2020 | 18 | 1,760 | 3,670 | $506,213 | $128,770 |
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Facility | 2021 | 183 | 968 | $95,832 | $24,973 | 26.1% |
| 88341 | Special stained specimen slides to examine tissue, each additional procedure | Office | 2021 | 32 | 275 | $89,925 | $24,644 | 27.4% |
| 88189 | Flow cytometry technique for dna or cell analysis, 16 or more markers | Facility | 2021 | 145 | 175 | $51,275 | $13,320 | 26.0% |
| 88185 | Flow cytometry technique for dna or cell analysis, each additional marker | Office | 2021 | 20 | 413 | $36,344 | $9,292 | 25.6% |
| 85097 | Bone marrow, smear interpretation | Facility | 2021 | 172 | 186 | $31,620 | $8,386 | 26.5% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Facility | 2021 | 180 | 200 | $26,200 | $6,752 | 25.8% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Facility | 2021 | 188 | 208 | $25,584 | $6,575 | 25.7% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Facility | 2021 | 170 | 565 | $23,730 | $6,300 | 26.5% |
| 88291 | Interpretation and report of genetic testing | Facility | 2021 | 141 | 184 | $20,976 | $5,797 | 27.6% |
| 88313 | Special stained specimen slides to examine tissue including interpretation and report | Office | 2021 | 21 | 46 | $11,914 | $3,646 | 30.6% |
| 88342 | Special stained specimen slides to examine tissue, initial procedure | Office | 2021 | 30 | 32 | $12,032 | $3,239 | 26.9% |
| 88377 | Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure | Facility | 2021 | 51 | 54 | $11,826 | $3,117 | 26.4% |
| 88305 | Pathology examination of tissue using a microscope, intermediate complexity | Office | 2021 | 27 | 35 | $8,400 | $2,353 | 28.0% |
| 88291 | Interpretation and report of genetic testing | Office | 2021 | 60 | 69 | $7,866 | $2,198 | 27.9% |
| 88160 | Screening examination of specimen cells, screening and interpretation | Facility | 2021 | 87 | 91 | $8,099 | $2,128 | 26.3% |
| 88311 | Preparation of tissue for examination by removing any calcium present | Facility | 2021 | 170 | 183 | $7,869 | $2,095 | 26.6% |
| 88321 | Surgical pathology consultation and report on referred slides prepared elsewhere | Office | 2021 | 21 | 22 | $7,590 | $1,935 | 25.5% |
| 88189 | Flow cytometry technique for dna or cell analysis, 16 or more markers | Office | 2021 | 25 | 25 | $7,325 | $1,928 | 26.3% |
| 85097 | Bone marrow, smear interpretation | Office | 2021 | 22 | 22 | $5,698 | $1,440 | 25.3% |
| 88184 | Flow cytometry technique for dna or cell analysis, first marker | Office | 2021 | 20 | 20 | $4,820 | $1,373 | 28.5% |
| 88377 | Microscopic genetic analysis of tissue, manual, each additional multiplex stain procedure | Office | 2021 | 16 | 16 | $22,032 | $923.36 | 4.2% |
| 88311 | Preparation of tissue for examination by removing any calcium present | Office | 2021 | 18 | 21 | $1,575 | $425.66 | 27.0% |
| 88341 | Special stained specimen slides to examine tissue | Facility | 2020 | 177 | 1,076 | $106,425 | $28,379 | 26.7% |
| 88189 | Flow cytometry technique for dna or cell analysis | Facility | 2020 | 158 | 266 | $77,938 | $20,791 | 26.7% |
| 88341 | Special stained specimen slides to examine tissue | Office | 2020 | 24 | 158 | $51,666 | $13,490 | 26.1% |
About Dr. Julie Feldstein, MD
Dr. Julie Feldstein, MD is a Anatomic Pathology healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/18/2006. The National Provider Identifier (NPI) number assigned to this provider is 1841270832.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Julie Feldstein, MD has received a total of $5,847 in payments from pharmaceutical and medical device companies, with $5,489 received in 2021. These payments were reported across 8 transactions from 5 companies. The most common payment nature is "Consulting Fee" ($3,479).
As a Medicare-enrolled provider, Feldstein has provided services to 3,559 Medicare beneficiaries, totaling 7,480 services with total Medicare billing of $261,608. Data is available for 2 years (2020–2021), covering 49 distinct procedure/service records.
Practice Information
- Specialty Anatomic Pathology
- Location New York, NY
- Active Since 01/18/2006
- Last Updated 07/08/2007
- Taxonomy Code 207ZP0101X
- Entity Type Individual
- NPI Number 1841270832
Products in Payments
- XOSPATA (Drug) $3,479
- XOLAIR (Biological) $240.26
- ADCETRIS (Biological) $100.87
- ELZONRIS (Drug) $16.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Anatomic Pathology Doctors in New York
Dr. Richard Axel, M.d, M.D
Anatomic Pathology — Payments: $96,602
Dr. Jeremy Segal, M.d., Ph.d, M.D., PH.D
Anatomic Pathology — Payments: $92,539
Marc Ladanyi, Md, MD
Anatomic Pathology — Payments: $74,599
Dr. Maureen Zakowski, Md, MD
Anatomic Pathology — Payments: $45,149
Victor Reuter, Md, MD
Anatomic Pathology — Payments: $44,326
Dr. Alexandros Polydorides, M.d., Ph.d, M.D., PH.D
Anatomic Pathology — Payments: $34,029